Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/110259
Title: | Oxidation of polysorbates - An underestimated degradation pathway? |
Author(s): | Weber, Johanna Buske, Julia Mäder, Karsten Garidel, Patrick Diederichs, Tim |
Issue Date: | 2023 |
Type: | Article |
Language: | English |
Abstract: | To ensure the stability of biologicals over their entire shelf-life, non-ionic surface-active compounds (surfactants) are added to protect biologics from denaturation and particle formation. In this context, polysorbate 20 and 80 are the most used detergents. Despite their benefits of low toxicity and high biocompatibility, specific factors are influencing the intrinsic stability of polysorbates, leading to degradation, loss in efficacy, or even particle formation. Polysorbate degradation can be categorized into chemical or enzymatic hydrolysis and oxidation. Under pharmaceutical relevant conditions, hydrolysis is commonly originated from host cell proteins, whereas oxidative degradation may be caused by multiple factors such as light, presence of residual metal traces, peroxides, or temperature, which can be introduced upon manufacturing or could be already present in the raw materials. In this review, we provide an overview of the current knowledge on polysorbates with a focus on oxidative degradation. Subsequently, degradation products and key characteristics of oxidative-mediated polysorbate degradation in respect of different types and grades are summarized, followed by an extensive comparison between polysorbate 20 and 80. A better understanding of the radical-induced oxidative PS degradation pathway could support specific mitigation strategies. Finally, buffer conditions, various stressors, as well as appropriate mitigation strategies, reagents, and alternative stabilizers are discussed. Prior manufacturing, careful consideration and a meticulous risk-benefit analysis are highly recommended in terms of polysorbate qualities, buffers, storage conditions, as well as mitigation strategies. |
URI: | https://opendata.uni-halle.de//handle/1981185920/112214 http://dx.doi.org/10.25673/110259 |
Open Access: | Open access publication |
License: | (CC BY-NC-ND 4.0) Creative Commons Attribution NonCommercial NoDerivatives 4.0 |
Journal Title: | International journal of pharmaceutics: X |
Publisher: | Elsevier |
Publisher Place: | Amsterdam |
Volume: | 6 |
Original Publication: | 10.1016/j.ijpx.2023.100202 |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S2590156723000464-main.pdf | 5.18 MB | Adobe PDF | View/Open |